Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros












Base de dados
Intervalo de ano de publicação
1.
Cell Biol Int ; 37(1): 36-46, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23319320

RESUMO

Adipose tissue is a potential site of retinoic acid (RA) action, but its physiological significance remains to be clarified. We have examined the effect of all-trans retinoic acid (ATRA) on growth and differentiation of preadipocytes, and on adipokine gene expression in mature adipocytes using human preadipocyte cell model, AML-I. Both ATRA and 9-cis RA induced growth arrest in AML-I preadipocyte at between 50 and 100 µM, which was accompanied by apoptosis. Western blotting showed a loss of NF-κB, Bcl-2 and p-Akt, and the accumulation of Bad and Akt in cytoplasm of ATRA-treated AML-I preadipocytes. Exposure of AML-I to ATRA or 9-cis RA increased intracellular lipid accumulation in a time-dependent manner compared to vehicle-treated cells. Expression of fatty acid synthase (FAS) and peroxisome proliferator-activated receptor-γ (PPAR-γ) proteins was increased in ATRA-treated cells. Thus, both ATRA and 9-cis RA promoted differentiation, inhibited proliferation and induced apoptosis in AML-I preadipocytes. ATRA also modulated adipokine expression by increasing the mRNA level of adipocytokines (adiponectin, leptin and LPL), and by inhibiting PAI-1 mRNA expression in mature AML-I adipocytes. The data suggest that ATRA exerts a wide range of effects--growth arrest, apoptosis, lipogenesis and modulation of adipokine gene expression--during the maturation of preadipocytes into adipocytes.


Assuntos
Adipocinas/genética , Subunidade alfa 2 de Fator de Ligação ao Core/genética , Tretinoína/farmacologia , Adipócitos/citologia , Adipócitos/efeitos dos fármacos , Adipócitos/metabolismo , Adipocinas/metabolismo , Linhagem Celular , Subunidade alfa 2 de Fator de Ligação ao Core/metabolismo , Ácido Graxo Sintase Tipo I/metabolismo , Humanos , Lipogênese/efeitos dos fármacos , PPAR gama/metabolismo , RNA Mensageiro/metabolismo
2.
Cell Biol Int ; 35(1): 51-9, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-20812919

RESUMO

We examined the effect of n-3 PUFAs (polyunsaturated fatty acids) on the growth and maturation of human preadipocyte cell line AML-I. On day 3 of the culture, n-3 fatty acids such as DHA (docosahexaenoic acid) and EPA (eicosapentaenoic acid), but not n-6 fatty acid LA (linoleic acid), induced growth arrest accompanied by the appearance of characteristics of apoptosis in AML-I cells at concentrations between 250 and 500 µM by Annexin V-FITC staining. In Western blotting analysis, the loss of NF-κB, Bcl-2 and p-Akt and the accumulation of Bad and Akt were observed in the cytoplasmic protein from the EPA-treated cells. Exposure of AML-I to EPA or DHA increased the cytoplasmic lipid accumulation compared with the vehicle-treated cells in a time-dependent manner during 4 and 6 days culture period by Oil Red O staining. The expression of FAS (fatty acid synthase) and PPAR-γ (peroxisome proliferator-activated receptor-γ) were increased in EPA-treated cells. These results suggest that EPA and DHA promote differentiation, inhibit proliferation and induce apoptosis in preadipocyte cell line AML-I.


Assuntos
Apoptose/efeitos dos fármacos , Células do Tecido Conjuntivo/efeitos dos fármacos , Ácidos Docosa-Hexaenoicos/farmacologia , Ácido Eicosapentaenoico/farmacologia , Lipogênese/efeitos dos fármacos , Células Cultivadas , Células do Tecido Conjuntivo/citologia , Células do Tecido Conjuntivo/metabolismo , Perfilação da Expressão Gênica , Humanos , Ácido Linoleico/farmacologia
3.
J Agric Food Chem ; 58(9): 5821-7, 2010 May 12.
Artigo em Inglês | MEDLINE | ID: mdl-20397699

RESUMO

Isoflavones are known to have several biological activities, including a hypolipidemic effect. However, the mechanism of the lipid lowering effect of genistein remains to be elucidated. There is conflicting evidence on the effect of genistein for the deposition of adipocyte tissues. We examined the effect of the isoflavones on the growth and differentiation of human preadipocyte cells, AML-I. Growth arrest accompanied by the appearance of characteristics of apoptosis was observed by genistein or daidzein treatment under the adipogenic stimulation. The expressions of apoptosis-related proteins, Bad, Akt, and p-Akt, were modulated in the genistein-treated cells by Western blot analysis. On the other hand, exposure of AML-I to the isoflavones increased accumulation of cytoplasmic lipid droplets. Actually, the cytoplasmic expressions of fatty acid synthase (FAS) and peroxisome proliferator-activated receptor (PPAR)-gamma were increased in the genistein-treated cells. Glycosylated forms of the isoflavones genistein and puerarin did not have such activities. These results suggested that only aglycon forms of isoflavones induced not only apoptosis but also lipogenesis in the preadipocyte cell line AML-I. The possible mechanism of these phenomena has been discussed in the text.


Assuntos
Adipócitos/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Genisteína/farmacologia , Isoflavonas/farmacologia , Adipócitos/citologia , Adipócitos/enzimologia , Adipócitos/metabolismo , Apoptose/efeitos dos fármacos , Ácido Graxo Sintases/metabolismo , Glicosilação , Humanos , PPAR gama/metabolismo
4.
J Agric Food Chem ; 56(22): 11030-7, 2008 Nov 26.
Artigo em Inglês | MEDLINE | ID: mdl-18980325

RESUMO

Citrus flavonoids are reported to be promising bioactive compounds against hyperlipidemia and lipid biosynthesis. However, the mechanism of the lipid lowering effect by flavonoids remains unknown. The present study examines the effect of some flavanones on the adipocytic conversion of the human preadipocyte cell line, AML-I. Among four structure-related flavanones including naringenin, naringenin-7-rhamnoglucoside (naringin), hesperetin, and hesperetin-7-rhamnoglucoside (hesperidin), the aglycones such as naringenin and hesperetin exhibited the growth arrest of AML-I cells. When the cells were examined by Annexin V-FITC staining method, it was noticed that growth arrest was induced by apoptotic cell death. In the study of apoptosis-related protein in the naringenin-treated cells, anti-apoptotic proteins such as p-Akt, NF-kappaB, and Bcl-2 were decreased, and pro-apoptotic protein Bad was accumulated by Western blot analysis. Interestingly, exposure of AML-I cells to naringenin or hesperetin during short-term cultures increased cytoplasmic lipid droplets by Sudan Black B staining. Furthermore, expression of fatty acid synthase (FAS) and peroxisome proliferator activated receptor (PPAR)-gamma was enhanced in naringenin-treated cells. These data suggest that apoptosis by flavanones does not inhibit the adipocytic conversion of AML-I preadipocytes. The result also indicates that adipocyte may not be a direct target for the lipid-lowering activity of the flavanones.


Assuntos
Adipócitos/efeitos dos fármacos , Apoptose/efeitos dos fármacos , Flavanonas/farmacologia , Hesperidina/farmacologia , Adipogenia/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Humanos
5.
Metabolism ; 56(12): 1656-65, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-17998018

RESUMO

Quercetin is involved in several biological activities including inhibition of cell growth and induction of apoptosis in cancer cells. However, it is unclear and unknown whether quercetin influences cell maturation. We examined the effect of quercetin on the growth and differentiation of human preadipocyte cells AML-I. Induced growth arrest of AML-I by quercetin was accompanied by the appearance of characteristics of apoptosis under the adipogenic stimulation by annexin V-fluorescein isothiocyanate staining method. A decrease of nuclear factor-kappaB and the antiapoptotic protein Mcl-1 and an increase of the proapoptotic protein Bad were observed in time-dependent fashion in the quercetin-treated cells compared with the vehicle-treated cells by Western blot analysis. Structure-related flavonoids, including rutin (quercetin-3-O-rutinoside) and quercitrin (quercetin-3-O-rhamnoside), did not have any cytotoxic effect on AML-I. Interestingly, exposure of AML-I to quercetin for 6 days increased the amount of cytoplasmic lipid droplets as well as the expression of fatty acid synthase and peroxisome proliferator-activated receptor gamma proteins. These results suggested that apoptosis induced by quercetin was not linked to adipogenic conversion of preadipocytes.


Assuntos
Adipócitos/efeitos dos fármacos , Antioxidantes/farmacologia , Apoptose/efeitos dos fármacos , Quercetina/farmacologia , Adipócitos/citologia , Adipócitos/metabolismo , Apoptose/fisiologia , Western Blotting , Diferenciação Celular/efeitos dos fármacos , Diferenciação Celular/fisiologia , Processos de Crescimento Celular/efeitos dos fármacos , Processos de Crescimento Celular/fisiologia , Linhagem Celular , Corantes Fluorescentes/química , Glicosilação/efeitos dos fármacos , Humanos , Metabolismo dos Lipídeos/efeitos dos fármacos , Microscopia de Fluorescência , Proteína de Sequência 1 de Leucemia de Células Mieloides , NF-kappa B/biossíntese , Proteínas de Neoplasias/biossíntese , PPAR gama/biossíntese , Proteínas Proto-Oncogênicas c-bcl-2/biossíntese , Proteína de Morte Celular Associada a bcl/biossíntese , Receptor fas/biossíntese
6.
Cell Biol Int ; 31(11): 1379-87, 2007 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17631393

RESUMO

In the present study, we examined the effect of epigallocatechin gallate (EGCG) on the growth and differentiation of human preadipocyte cells, AML-I. EGCG exhibited cytotoxic activity on AML-I cells, accompanied by the appearance of characteristics of apoptosis by Annexin V-FITC staining method. Among apoptosis-related proteins examined, loss of NF-kappaB and p-Akt, and accumulation of Bad were displayed in EGCG-treated cells by Western blot analysis. Among 6 structure-related catechins including catechin (C), epicatechin (EC), catechin gallate (CG), epigallocatechin (EGC), epicatechin gallate (ECG) and EGCG, the catechins containing galloyl moiety exhibited apoptotic capacity. Interestingly, exposure of AML-I to EGCG increased the amounts of cytoplasmic lipid droplets as well as the expression of fatty acid synthase and peroxisome proliferator activated receptor-gamma proteins. Our results suggest that EGCG induces growth arrest and apoptosis, but does not affect adipocyte conversion of preadipocytes.


Assuntos
Adipócitos/efeitos dos fármacos , Adipogenia/efeitos dos fármacos , Apoptose/efeitos dos fármacos , Catequina/análogos & derivados , Adipócitos/citologia , Adipócitos/metabolismo , Proteínas Reguladoras de Apoptose/metabolismo , Catequina/metabolismo , Catequina/toxicidade , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Humanos , PPAR gama/metabolismo , Receptor fas/metabolismo
7.
Int Immunopharmacol ; 5(13-14): 1830-8, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16275619

RESUMO

There is a growing body of evidences suggesting the important role of vitamin A for the optimal maintenance and functioning of immune system. It is now well established that retinoic acid (RA), a product of oxidative metabolism of vitamin A, is the most active vitamin A derivative physiologically. In this study, we examined the role of RA in B cell maturation in T cell-dependent activation pathway. RA enhanced the immunoglobulin synthesis by tonsillar B cells in anti-CD40 plus IL-10-mediated culture system. When the kinetics of B cells with different phenotypic characteristics were monitored during 9 days culture period by flow cytometric analysis, it displayed the increase of the B cells with plasma cell phenotype (CD38+/CD20-/IgD-) in the presence of RA. As resting B cells from tonsil expressed mRNA of the RA receptors alpha, beta, gamma and RXRalpha by reverse transcriptase-polymerase chain reaction, it is certain that RA effect is mediated by RA receptors. Taken together, this study showed that retinoic acid could accelerate the differentiation of B cells maturing into antibody producing cells.


Assuntos
Linfócitos B/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , RNA Mensageiro/análise , Tretinoína/farmacologia , ADP-Ribosil Ciclase 1/metabolismo , Linfócitos B/citologia , Linfócitos B/metabolismo , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Técnicas de Cocultura , Relação Dose-Resposta a Droga , Humanos , Imunoglobulinas/metabolismo , Imunofenotipagem , Tonsila Palatina/citologia , Plasmócitos/citologia , Plasmócitos/metabolismo , Receptores do Ácido Retinoico/genética , Receptores do Ácido Retinoico/metabolismo , Transdução de Sinais/efeitos dos fármacos , Fatores de Tempo
8.
Int J Antimicrob Agents ; 25(1): 44-50, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15620825

RESUMO

Biofilms are a major concern for clinicians in the treatment of infectious disease because of the resistance to a wide range of antibiotics. Using a rat air pouch model, methicillin-resistant Staphylococcus aureus (MRSA) growing as a biofilm was treated with a combination of fosfomycin (FOM) and arbekacin (ABK) or by the agents alone. This model has the advantage of permitting frequent sampling of exudates for bacterial counts and anti-bacterial activity, and morphological examination of the biofilm structure and inflammatory process in the pouch tissues. A clear synergistic effect was observed in the rats treated with a combination of fosfomycin and arbekacin. Morphological studies using scanning electron microscopy and histological staining showed dramatic changes of the biofilm structure as well as the inflammatory response in the rats. These results suggested an enhancement of bactericidal activity of arbekacin penetrating through the biofilm layer by virtue of fosfomycin. A possible mechanism of the synergistic effect is discussed.


Assuntos
Aminoglicosídeos/farmacologia , Antibacterianos/farmacologia , Biofilmes/efeitos dos fármacos , Dibecacina/análogos & derivados , Dibecacina/farmacologia , Fosfomicina/farmacologia , Resistência a Meticilina , Staphylococcus aureus/efeitos dos fármacos , Animais , Biofilmes/crescimento & desenvolvimento , Modelos Animais de Doenças , Sinergismo Farmacológico , Granuloma/microbiologia , Masculino , Testes de Sensibilidade Microbiana , Ratos , Ratos Wistar , Infecções Estafilocócicas/tratamento farmacológico , Infecções Estafilocócicas/microbiologia , Staphylococcus aureus/crescimento & desenvolvimento
9.
J Infect Chemother ; 10(5): 268-73, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16163460

RESUMO

Biofilms are a major concern for clinicians in the treatment of infectious disease because of their resistance to a wide range of antibiotics. Arbekacin, an aminoglycoside antibiotic, is the drug of choice for the treatment of infection caused by methicillin-resistant Staphylococcus aureus (MRSA). However, it has not yet been defined whether arbekacin tends to penetrate into the biofilm structure induced by MRSA infection. In this study, we treated a biofilm mode of MRSA growth with arbekacin, using a rat air-pouch model. The model has the advantage of permitting frequent sampling of exudates for bacterial counts and antibacterial activity. A clear dose-dependent bactericidal effect was detected in rats treated with arbekacin at concentrations between 0.3 and 10 mg/kg, but 0.1 mg/kg of arbekacin was ineffective against the experimental MRSA infection in rats. Morphological studies using scanning electron microscopy and histochemical staining demonstrated that an effective dosage of arbekacin induced dramatic changes in the biofilm membranous structure as well as in the inflammatory response, resulting in eradication of the biofilm structure and resolution of inflammation.


Assuntos
Aminoglicosídeos/uso terapêutico , Antibacterianos/uso terapêutico , Biofilmes/efeitos dos fármacos , Dibecacina/análogos & derivados , Resistência a Meticilina , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/efeitos dos fármacos , Aminoglicosídeos/farmacologia , Animais , Antibacterianos/farmacologia , Biofilmes/crescimento & desenvolvimento , Dibecacina/farmacologia , Dibecacina/uso terapêutico , Modelos Animais de Doenças , Granuloma/tratamento farmacológico , Humanos , Masculino , Microscopia Eletrônica de Varredura , Necrose , Ratos , Ratos Wistar , Infecções Estafilocócicas/microbiologia , Infecções Estafilocócicas/patologia , Staphylococcus aureus/crescimento & desenvolvimento , Staphylococcus aureus/ultraestrutura , Resultado do Tratamento
10.
Life Sci ; 74(6): 709-21, 2003 Dec 26.
Artigo em Inglês | MEDLINE | ID: mdl-14654164

RESUMO

We examined the effect of quercetin on the inflammatory response induced by carrageenan in the rat. Air pouches were induced subcutaneously on the backs of rats and injected with carrageenan. The rats were treated with either vehicle or quercetin at a dose of 10 mg/kg one hour before carrageenan challenge. Fourty-eight hour after carrageenan challenge, the air pouches were removed and analyzed. The volume, protein amounts and cell counts in the exudation obtained from the quercetin-treated animals were significantly reduced compared to those from vehicle-treated animals. The contents of PGE(2), TNF-alpha, RANTES, MIP-2 and the mRNA for cyclooxygenase-2 were also suppressed in these rats. The histological examination displayed the suppression of the inflammatory response in the pouch tissues from quercetin-treated rats. As the anti-inflammatory effect of the flavonols was more or less at the similar level among the quercetin-, isoquercitrin- or rutin-treated rats, it appeared that the sugar parts did not influence on the anti-inflammatory effect. Our study indicated that the flavonols modulated the inflammatory response, at least in part, by modulating the prostanoid synthesis as well as cytokine production.


Assuntos
Anti-Inflamatórios/uso terapêutico , Quimiocinas CXC , Inflamação/prevenção & controle , Peptídeos e Proteínas de Sinalização Intercelular , Quercetina/uso terapêutico , Animais , Carragenina , Quimiocina CCL5/metabolismo , Quimiocina CXCL2 , Ciclo-Oxigenase 2 , Dinoprostona/metabolismo , Modelos Animais de Doenças , Exsudatos e Transudatos/efeitos dos fármacos , Exsudatos e Transudatos/metabolismo , Membro Posterior , Inflamação/induzido quimicamente , Inflamação/metabolismo , Isoenzimas/genética , Isoenzimas/metabolismo , Masculino , Monocinas/metabolismo , Prostaglandina-Endoperóxido Sintases/genética , Prostaglandina-Endoperóxido Sintases/metabolismo , RNA Mensageiro/metabolismo , Ratos , Ratos Wistar , Fator de Necrose Tumoral alfa/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...